Clinical Trial Update: Gingival Recession Coverage With and Without Emdogain [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update evaluating gingival recession coverage with Emdogain versus without Emdogain. The study, sponsored by the University of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gingival Recession

Drugs mentioned

• Emdogain (Enamel Matrix Derivative)

Snippet

Sponsor: University of Bern | Conditions: Gingival Recession, Emdogain | Phase 4 | Status: COMPLETED